References
- Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733.
- Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6
- Huang CW, Wee PH, Low LL, et al. Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2021;69:27–40. doi:10.1016/j.genhosppsych.2020.12.003
- Yeam CT, Chia S, Tan H, Kwan YH, Fong W, Seng J. A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int. 2018;29(12):2623–2637. doi:10.1007/s00198-018-4759-3
- Seng J, Tan JY, Yeam CT, Htay H, Foo W. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature. Int Urol Nephrol. 2020;52(5):903–916. doi:10.1007/s11255-020-02452-8
- Kwan YH, Weng SD, Loh D, et al. Measurement properties of existing patient-reported outcome measures on medication adherence: systematic review. J Med Internet Res. 2020;22(10):e19179. doi:10.2196/19179
- Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WJ. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64(3):250–254. doi:10.1016/j.jclinepi.2010.07.014
- Tan J, Luo L, Zhang M, et al. A Chinese and Western medication adherence scale in patients with chronic kidney disease. Patient Prefer Adherence. 2019;13:1487–1495. doi:10.2147/PPA.S207693
- Huang Q, Luo L, Xia BQ, et al. Refinement and evaluation of a Chinese and Western medication adherence scale for patients with chronic kidney disease: item response theory analyses. Patient Prefer Adherence. 2020;14:2243–2252. doi:10.2147/PPA.S269255
- [No authors listed].Erratum: Kidney Disease: improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1-59. Kidney Int Suppl. 2017;7(3):e1. doi:10.1016/j.kisu.2017.10.001
- Cedillo-Couvert EA, Ricardo AC, Chen J, et al. Self-reported medication adherence and CKD progression. Kidney Int Rep. 2018;3(3):645–651. doi:10.1016/j.ekir.2018.01.007
- Hsu KL, Fink JC, Ginsberg JS, et al. Self-reported medication adherence and adverse patient safety events in CKD. Am J Kidney Dis. 2015;66(4):621–629. doi:10.1053/j.ajkd.2015.03.026
- Park MS, Kang KJ, Jang SJ, Lee JY, Chang SJ. Evaluating test-retest reliability in patient-reported outcome measures for older people: a systematic review. Int J Nurs Stud. 2018;79:58–69. doi:10.1016/j.ijnurstu.2017.11.003
- Luo L, Zhang M, Chen HF, et al. Validity, reliability, and application of the electronic version of a chronic kidney disease patient awareness questionnaire: a pilot study. Postgrad Med. 2021;133(1):48–56. doi:10.1080/00325481.2020.1801029